Publicaciones en colaboración con investigadores/as de Complejo Hospitalario Torrecárdenas de Almería (20)

2024

  1. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study

    Multiple Sclerosis and Related Disorders, Vol. 90

  2. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 10, pp. 2062-2074.e11

  3. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615

  4. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy

    Hepatology (Baltimore, Md.), Vol. 80, Núm. 4, pp. 791-806

2023

  1. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

2022

  1. Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study

    Cancers, Vol. 14, Núm. 24

  2. Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

    Gut, Vol. 71, Núm. 10, pp. 2138-2140

2021

  1. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

    Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362

  2. Hemodialysis Centers Guide 2020

    Nefrologia, Vol. 41, pp. 1-77

  3. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

    American Journal of Gastroenterology, Vol. 116, Núm. 11, pp. 2250-2257

2020

  1. Impacto de la pandemia COVID-19 en los servicios de Nefrología españoles

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 6, pp. 579-584

  2. Predicting clinical outcome with phenotypic clusters in covid-19 pneumonia: An analysis of 12,066 hospitalized patients from the spanish registry semi-covid-19

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-19

  3. Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant

    Nefrologia, Vol. 40, Núm. 3, pp. 253-257

  4. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 3, pp. 272-278

2019

  1. Document on a comprehensive approach to type 2 diabetes mellitus

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 7, pp. 443-458

  2. The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem

    Nefrologia

2018

  1. Visceral Leishmaniasis in Renal Transplant Recipients: Report of 2 Cases

    Transplantation Proceedings, Vol. 50, Núm. 2, pp. 581-582

2017

  1. Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

    Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8

2013

  1. Evaluación de la calidad de vida mediante cuestionario PRIMUS en población española de pacientes con esclerosis múltiple

    Neurologia, Vol. 28, Núm. 6, pp. 340-347

2012

  1. Kidney transplantation with grafts from type III Maastricht death cardiac donors

    Nefrologia, Vol. 32, Núm. 6, pp. 760-766